Manfred Jung

Cited by

	All	Since 2019
Citations	15354	6530
h-index	69	40
i10-index	229	175

1300

650

325

975

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202485 170 175 206 209 247 336 429 503 504 665 682 698 813 912 932 1050 1004 1270 1224 1181 1040 808

Public access

View all

141 articles

50 articles

available

not available

Based on funding mandates

Co-authors

Wolfgang SipplProfessor of Medicinal ChemistryVerified email at pharmazie.uni-halle.de
Martin MarekResearch Scientist & Team Leader, Loschmidt Laboratories, Masaryk UniversityVerified email at recetox.muni.cz
Eric VerdinCEO & President, Buck Institute for Research on AgingVerified email at buckinstitute.org
Attila LehotzkyInstitute of Enzymology, HUN-RESVerified email at ttk.hu
Guilherme OliveiraInstituto Tecnológico ValeVerified email at itv.org
Lucia Altucci, MD, PhDSeconda Università di NapoliVerified email at unina2.it
Stefan GüntherProfessor for Pharmaceutical Bioinformatics, Freiburg UniversityVerified email at pharmazie.uni-freiburg.de
Antonello MaiProfessore di Chimica Farmaceutica, Sapienza Università di RomaVerified email at uniroma1.it
David ChristiansonProfessor of Chemistry, University of PennsylvaniaVerified email at sas.upenn.edu
Bernhard BreitAlbert-Ludwigs-Universität FreiburgVerified email at chemie.uni-freiburg.de
Brian J. NorthCreighton University School of MedicineVerified email at creighton.edu
Clarissa GerhauserGroup Leader, German Cancer Research Center (dkfz.) HeidelbergVerified email at dkfz.de
Melanie OttVerified email at gladstone.ucsf.edu
Dante Rotili, PhDProfessor of Medicinal Chemistry, "Sapienza" University of RomeVerified email at uniroma1.it
Xavier LucasSenior scientist in computational drug design at Monte Rosa Therapeutics, BaselVerified email at monterosatx.com
Matthias KassackProfessorVerified email at uni-duesseldorf.de
Martin PippelBioinformatician, NBIS - National Bioinformatics Infrastructure SwedenVerified email at nbis.se
Suhaib ShekfehMartin-Luther-University Medicinal ChemistryVerified email at pharmazie.uni-hale.de
David A. SinclairHarvard Medical School (Genetics)Verified email at hms.harvard.edu
Huanbiao MoProfessor of Nutrition, Georgia State UniversityVerified email at gsu.edu

Manfred Jung

Institute of Pharmaceutical Sciences, University of Freiburg; former University of Münster, Ottawa

Verified email at pharmazie.uni-freiburg.de - Homepage

Medicinal Chemistry Chemical Biology: Chemical Epigenetics Histone acetyltransferases deacetylases methyltransferases


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy K Keller, M Jung Epigenetic Therapy of Cancer: Preclinical Models and Treatment Approaches …, 2013	469	2013
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy L Morera, M Lübbert, M Jung Clinical epigenetics 8, 1-16, 2016	429	2016
SIRT1 regulates HIV transcription via Tat deacetylation S Pagans, A Pedal, BJ North, K Kaehlcke, BL Marshall, A Dorr, ... PLoS biology 3 (2), e41, 2005	428	2005
Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals) M Schiedel, D Herp, S Hammelmann, S Swyter, A Lehotzky, D Robaa, ... Journal of medicinal chemistry 61 (2), 482-491, 2018	295	2018
Inhibitors of histone deacetylase as new anticancer agents M Jung Current Medicinal Chemistry 8 (12), 1505-1511, 2001	285	2001
HDAC8: a multifaceted target for therapeutic interventions A Chakrabarti, I Oehme, O Witt, G Oliveira, W Sippl, C Romier, RJ Pierce, ... Trends in pharmacological sciences 36 (7), 481-492, 2015	281	2015
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site T Rumpf, M Schiedel, B Karaman, C Roessler, BJ North, A Lehotzky, ... Nature communications 6 (1), 6263, 2015	280	2015
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation M Jung, G Brosch, D Kölle, H Scherf, C Gerhäuser, P Loidl Journal of Medicinal Chemistry 42 (22), 4669-4679, 1999	270	1999
Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD⁺‐Dependent Histone Deacetylases (Sirtuins) J Trapp, R Meier, D Hongwiset, MU Kassack, W Sippl, M Jung ChemMedChem: Chemistry Enabling Drug Discovery 2 (10), 1419-1431, 2007	241	2007
Structure–activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode RC Neugebauer, U Uchiechowska, R Meier, H Hruby, V Valkov, E Verdin, ... Journal of medicinal chemistry 51 (5), 1203-1213, 2008	205	2008
The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors A Spannhoff, AT Hauser, R Heinke, W Sippl, M Jung ChemMedChem: Chemistry Enabling Drug Discovery 4 (10), 1568-1582, 2009	204	2009
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition J Trapp, A Jochum, R Meier, L Saunders, B Marshall, C Kunick, E Verdin, ... Journal of medicinal chemistry 49 (25), 7307-7316, 2006	204	2006
Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni M Marek, S Kannan, AT Hauser, M Moraes Mourão, S Caby, V Cura, ... PLoS pathogens 9 (9), e1003645, 2013	200	2013
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors Y Zhang, M Jung, A Dritschilo, M Jung Radiation research 161 (6), 667-674, 2004	175	2004
Target-based approach to inhibitors of histone arginine methyltransferases A Spannhoff, R Heinke, I Bauer, P Trojer, E Metzger, R Gust, R Schüle, ... Journal of medicinal chemistry 50 (10), 2319-2325, 2007	173	2007
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates SW Remiszewski, LC Sambucetti, P Atadja, KW Bair, WD Cornell, ... Journal of medicinal chemistry 45 (4), 753-757, 2002	171	2002
Subtype selective substrates for histone deacetylases B Heltweg, F Dequiedt, BL Marshall, C Brauch, M Yoshida, N Nishino, ... Journal of medicinal chemistry 47 (21), 5235-5243, 2004	160	2004
Impairment of prostate cancer cell growth by a selective and reversible LSD1 inhibitor D Willmann, S Lim, S Wetzel, E Metzger, A Jandausch, W Wilk, M Jung, ... International Journal of Cancer 128, 574-586, 2012	156*	2012
In vitro assays for the determination of histone deacetylase activity B Heltweg, J Trapp, M Jung Methods 36 (4), 332-337, 2005	153	2005
Characterization of novel inhibitors of histone acetyltransferases ED Eliseeva, V Valkov, M Jung, MO Jung Molecular cancer therapeutics 6 (9), 2391-2398, 2007	147	2007

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors